Finding Value for our Partners
SCYNEXIS is seeking unique compound collections that have not been exploited as potential starting points for the development of new treatments for parasitic diseases. Evaluation of these compound sets in the SCYNEXIS Integrated Parasitology platform represents an exciting opportunity for the discovery of new treatments for human and animal parasitic diseases. SCYNEXIS is offering to screen up to 500 representative compounds from compound collections against a select panel of parasites for free. These parasites represent species relevant to the areas of Human, Animal, and Public Health.
SCYNEXIS has established partnerships with the top Animal Health and Public Health companies in the world. These for-profit organizations are actively seeking high-value compound collections that have validated parasite and vector activity. These partnerships have enabled SCYNEXIS to build a well characterized collection of Target Product Profiles (TPPs) for each organization. As compound series evaluated in the SCYNEXIS Integrated Parasitology platform meet the criteria for a specific TPP, SCYNEXIS can quickly align organizations to drive their discovery programs forward.
We would be happy to discuss our technical expertise and business model with you in more detail to determine opportunities to work with your organization.